SEC CIK 1753788
Lefebvre Mojgan M
Reported ownership across 2 companies, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| UNMview stock → | 15,269 | 2026-05-26 |
| TRVview stock → | 7,100 | 2026-07-21 |
Position History — TRV
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — TRV
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2026-07-21 | Option exercise (derivative) | 7,100 | $0.00 | 21,214 |
| 2026-07-21 | Option exercise (derivative) | 9,213 | $0.00 | 0 |
| 2026-07-21 | Option exercise | 7,100 | $139.83 | 7,100 |
| 2026-07-21 | Open-market sale | 9,213 | $368.35 | 0 |
| 2026-07-21 | Option exercise | 9,213 | $132.58 | 9,213 |
| 2026-02-19 | Open-market sale | 5,826.654 | $298.25 | 0 |
| 2026-02-18 | Tax withholding | 6,182 | $298.46 | 5,826.654 |
| 2026-02-18 | Grant / award | 12,008.654 | $0.00 | 12,008.654 |
| 2026-02-03 | Grant / award (derivative) | 10,651 | $0.00 | 10,651 |
| 2025-08-22 | Option exercise (derivative) | 16,820 | $0.00 | 9,213 |
| 2025-08-22 | Open-market sale | 16,820 | $277.54 | 0 |
| 2025-08-22 | Option exercise | 16,820 | $132.58 | 16,820 |
| 2025-05-29 | Open-market sale | 6,148.68 | $273.71 | 0 |
| 2025-02-26 | Option exercise (derivative) | 13,300 | $0.00 | 26,033 |
| 2025-02-26 | Open-market sale | 13,300 | $248.60 | 6,148.68 |
| 2025-02-26 | Option exercise | 13,300 | $132.58 | 19,448.68 |
| 2025-02-19 | Grant / award | 12,524.68 | $0.00 | 12,524.68 |
| 2025-02-19 | Tax withholding | 6,376 | $241.05 | 6,148.68 |
| 2025-02-04 | Grant / award (derivative) | 11,571 | $0.00 | 11,571 |
| 2024-10-21 | Option exercise (derivative) | 18,736 | $0.00 | 0 |
| 2024-10-21 | Option exercise (derivative) | 2,300 | $0.00 | 39,333 |
| 2024-10-21 | Open-market sale | 912 | $261.19 | 0 |
| 2024-10-21 | Open-market sale | 15,168 | $259.27 | 5,868 |
| 2024-10-21 | Option exercise | 2,300 | $132.58 | 21,036 |
| 2024-10-21 | Option exercise | 18,736 | $126.18 | 18,736 |
| 2024-10-21 | Open-market sale | 4,956 | $260.08 | 912 |
| 2024-02-22 | Option exercise (derivative) | 12,500 | $0.00 | 18,736 |
| 2024-02-22 | Option exercise | 12,500 | $126.18 | 12,500 |
| 2024-02-22 | Open-market sale | 6,215.96 | $220.00 | 0 |
| 2024-02-21 | Tax withholding | 6,599 | $219.38 | 6,215.96 |
| 2024-02-21 | Grant / award | 12,814.96 | $0.00 | 12,814.96 |
| 2024-02-06 | Grant / award (derivative) | 12,667 | $0.00 | 12,667 |
| 2023-02-23 | Open-market sale | 5,374.83 | $183.49 | 0 |
| 2023-02-22 | Grant / award | 7,993.85 | $0.00 | 9,013.83 |
| 2023-02-22 | Tax withholding | 3,639 | $185.61 | 5,374.83 |
| 2023-02-07 | Grant / award (derivative) | 14,964 | $0.00 | 14,964 |
| 2022-08-24 | Open-market sale | 2,945 | $168.33 | 1,019.99 |
| 2022-02-23 | Tax withholding | 3,271 | $171.50 | 3,964.99 |
| 2022-02-23 | Grant / award | 7,235.99 | $0.00 | 7,235.99 |
| 2022-02-08 | Grant / award (derivative) | 20,024 | $0.00 | 20,024 |
| 2022-02-04 | Open-market sale | 3,115 | $172.52 | 0 |
| 2021-10-26 | Open-market sale | 1,038 | $160.73 | 3,115 |
| 2021-10-15 | Tax withholding | 37 | $157.01 | 4,153 |
| 2021-09-21 | Tax withholding | 3,329 | $152.95 | 4,190 |
| 2021-02-02 | Grant / award (derivative) | 28,314 | $0.00 | 28,314 |
| 2020-02-04 | Grant / award (derivative) | 41,633 | $0.00 | 41,633 |
| 2019-02-05 | Grant / award (derivative) | 31,236 | $0.00 | 31,236 |
| 2018-10-15 | Grant / award | 81 | $0.00 | 7,519 |
| 2018-09-21 | Grant / award | 7,438 | $0.00 | 7,438 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.